Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This study's primary aim is to compare time to relapse and relapse rates in responders to
acute escitalopram who are then randomized to placebo versus continuation treatment with
escitalopram.
Phase:
Phase 3
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
National Institute of Mental Health (NIMH) Rhode Island Hospital